Skip to content

Medical vaccine

ACAM2000 (Smallpox Vaccine)

CAS 860435-78-5
5

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

ACAM2000 is a live vaccinia virus smallpox vaccine. It is a prescription medical product with serious risks including myocarditis and viral transmission, and has no legitimate use in cosmetics or skincare.

Skin benefits

  • Provides immunity against smallpox and monkeypox when used as a medical vaccine
  • Approved by FDA for prevention of smallpox in high-risk individuals

Known concerns

  • Live vaccinia virus vaccine, never intended for cosmetic use
  • Can cause myocarditis, pericarditis, eczema vaccinatum and progressive vaccinia
  • Risk of viral transmission to contacts via the vaccination site
  • Has no legitimate role in any cosmetic or skincare product
  • Use outside medical supervision is dangerous and likely illegal

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find ACAM2000 (Smallpox Vaccine) in your products.

Scan any cosmetic product with LuxSense to see if it contains ACAM2000 (Smallpox Vaccine) and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.